ZNTL vs CBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 10, 2026

ZNTL

69.8
AI Score
VS
ZNTL Wins

CBIO

42.4
AI Score

Investment Advisor Scores

ZNTL

70score
Recommendation
BUY

CBIO

42score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ZNTL CBIO Winner
Net Income -101.84M -48.12M CBIO
Operating Income -115.42M -51.09M CBIO
ROE -40.3% -29.5% CBIO
ROA -31.1% -26.3% CBIO
Total Assets 327.25M 182.76M ZNTL
Cash 39.07M 171.59M CBIO
Current Ratio 7.76 9.66 CBIO

Relative Price Performance (Last 90 Days)

ZNTL 1M: -27.6% · 3M: -52.8% CBIO 1M: +14.2% · 3M: -16.2%

Current Technical Phase

ZNTL

Markdown
Sell / avoid

Price below a falling SMA50 (slope -23.2%), weak momentum, RSI 30

RSI (14): 30.4 · Price: $1.68

CBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 54

RSI (14): 54.3 · Price: $14.37

Fundamentals Snapshot

Metric ZNTL CBIO
Market Cap — —
Forward P/E -1.1 -5.5
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin 1.0% 1.0%
Operating Margin 0.0% -14.3%
EPS -1.90 -7.20
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ZNTL is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.